← Eichor
Study identifier: NCT06561139 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mindfulness as an add-on Intervention in Treatment for Problem Gambling in Clinical Settings in Sweden

Condition: Problem Gambling  ·  Sponsor: Region Skane

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will test the effects of an add-on mindfulness intervention for patients with gambling problems, added to treatment as usual, compared to a waitlist control condition. The study will primarily aim to decrease gambling behaviour compared to the control condition which receives the intervention later, after two months, and secondarily to decrease symptoms of depressive and anxiety symptoms. In addition, patients who have undergone the mindfulness intervention will be offered participation in a qualitative interview study aiming to deepen the understanding of feasibility and challenges of a mindfulness add-on intervention against gambling problems.

This description comes directly from the study's public registry record.

Talk to the study team

Anders Håkansson, PhD  ·  +46 46 175596  ·  anders_c.hakansson@med.lu.se

Patrick Bacquin, nurse  ·  patrick.bacquin@skane.se

Always discuss trial participation with your own doctor first.

Locations (1)

Malmö Addiction CenterMalmö, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06561139